GS-444217

1 1

Selleck Chemicals

S0067-5MG

€419,00 EUR
€419,00 EUR
Sale Sold out
Taxes included. Shipping calculated at checkout.
Size
View full details

GS-444217 is an inhibitor linked to Apoptosis and related pathway-oriented research. It is especially relevant when investigators need a named chemical input and interpretable readouts connected to caspase-associated cell-death signaling and survival decisions in apoptosis and cancer models.

The pathway annotation connects GS-444217 to Apoptosis, supporting experiments that monitor caspase-associated cell-death signaling and survival decisions across biochemical, cellular, or phenotypic assay formats. This context is compatible with apoptosis, viability, and caspase-readout assays, as well as transcriptional, biochemical, or phenotypic comparisons linked to the annotated pathway state. In apoptosis and cancer models, these readouts can be combined with viability, reporter, localization, biochemical conversion, or morphology endpoints to refine experimental interpretation.

Research Applications

  • Pathway perturbation studies connected to Apoptosis
  • Concentration-response inhibition and target-dependence studies
  • Phenotypic profiling in apoptosis and cancer models
  • Combination studies with orthogonal perturbagens

Overall, GS-444217 is well suited to pathway-oriented studies that need a defined compound input for Apoptosis readouts in apoptosis and cancer models. This profile is suited to mechanistic follow-up, comparative profiling, and assay optimization under defined exposure conditions.

Pathways:
Apoptosis
Research Area:
Apoptosis • Cancer
CAS No.:
1262041-49-5
Molecular Weight:
411.46
Formula:
C₂₃H₂₁N₇O
SMILES:
C1CC1C2=CN(C=N2)C3=CC(=NC=C3)C(=O)NC4=CC=CC(=C4)C5=NN=CN5C6CC6
Storage Temperature:
-20°C

For Research Use Only. Not intended for diagnostic or therapeutic use.
Products may be subject to intellectual property rights.

The purchase of this product does not grant any license for commercial use, manufacturing, or clinical applications. The user is responsible for ensuring compliance with applicable laws and third-party rights.